Approved Hospital Formulary
Add Formweb to your mobile device
Search results for:
risperiDONE
risperiDONE
Brand names: RisperDAL Consta
| Form | Strength |
|---|---|
| POWDER FOR INJECTION, EXTENDED RELEASE, INTRAMUSCULAR | 12.5 mg/2 weeks; 25 mg/2 weeks; 37.5 mg/2 weeks; 50 mg/2 weeks |
| SOLUTION, ORAL | 1 mg/mL |
| TABLET, DISINTEGRATING, ORAL | 0.5 mg; 1 mg; 2 mg |
| TABLET, ORAL | 0.5 mg; 1 mg; 2 mg; 3 mg; 4 mg |
Last updated: Apr. 1, 2022
- Black Box Warning: Elderly patients with dementia related psychosis
Risperidone
Use for delerium in a ventilated Critical Care patient: See Guideline 901.5008